Year: 2021
Type: article
Abstract: Successful treatment of erythema nodosum leprosum with apremilastDear Editor, Leprosy is an infectious disease caused by Mycobacterium leprae and M. lepromatosis.It mainly affects skin and peripheral nerves, being its clinical presentation strongly dependent on the host's immune response.1 The morbidities and deformities caused by the infection, along with the reemergence of this illness experienced both in Eastern and Western countries, make leprosy a particularly relevant disease still nowadays.2 Lepromatous reactions (LR) are immune-mediated inflammatory complications of leprosy.Erythema nodosum leprosum (ENL), also known as type 2 reaction, is an acute LR that may occur before, during or after multidrug therapy.It is mostly related to borderline leprosy (BL) and lepromatous leprosy (LL). 1 It is a relapsing affection often needing of long-term treatments.3 We present a case of ENL successfully treated with the phosphodiesterase-4 (PDE-4) inhibitor apremilast.A 20-years-old woman was diagnosed of multibacillary LL.She
Source: Dermatologic Therapy
DOI: 10.1111/dth.15258
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4200219212
